STERIS PLC (NYSE:STE) will be posting its quarterly earnings results before the market opens on Wednesday, November 1st. Analysts expect STERIS PLC to post earnings of $0.95 per share for the quarter. STERIS PLC has set its FY18 guidance at $3.96-4.09 EPS.

STERIS PLC (NYSE:STE) last issued its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping the consensus estimate of $0.80 by $0.05. The company had revenue of $608.00 million during the quarter, compared to analyst estimates of $597.66 million. STERIS PLC had a return on equity of 11.39% and a net margin of 4.63%. The business’s revenue was down 4.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.79 EPS. On average, analysts expect STERIS PLC to post $4.06 EPS for the current fiscal year and $4.54 EPS for the next fiscal year.

STERIS PLC (STE) opened at 91.23 on Wednesday. STERIS PLC has a 12 month low of $63.80 and a 12 month high of $92.20. The stock has a 50 day moving average price of $88.65 and a 200 day moving average price of $82.00. The firm has a market cap of $7.78 billion, a price-to-earnings ratio of 65.26 and a beta of 1.29.

The company also recently declared a quarterly dividend, which was paid on Thursday, September 28th. Investors of record on Tuesday, August 29th were paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 1.36%. This is a positive change from STERIS PLC’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, August 25th. STERIS PLC’s payout ratio is currently 88.57%.

Several equities analysts recently issued reports on STE shares. Zacks Investment Research upgraded STERIS PLC from a “hold” rating to a “buy” rating and set a $101.00 price target on the stock in a research note on Monday, October 9th. KeyCorp reiterated a “buy” rating and issued a $91.00 price objective on shares of STERIS PLC in a research note on Tuesday, October 17th. Raymond James Financial, Inc. upped their price objective on STERIS PLC from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, August 9th. Finally, BidaskClub lowered STERIS PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. STERIS PLC currently has a consensus rating of “Buy” and an average target price of $90.75.

In other STERIS PLC news, insider Michael J. Tokich sold 11,000 shares of the company’s stock in a transaction on Monday, October 23rd. The stock was sold at an average price of $92.00, for a total transaction of $1,012,000.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the company’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $85.69, for a total value of $856,900.00. Following the transaction, the chief executive officer now directly owns 83,270 shares in the company, valued at approximately $7,135,406.30. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 205,086 shares of company stock worth $17,965,621. 2.55% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “STERIS PLC (STE) to Release Earnings on Wednesday” was posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/10/25/steris-plc-ste-to-release-earnings-on-wednesday.html.

STERIS PLC Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Earnings History for STERIS PLC (NYSE:STE)

Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with MarketBeat.com's FREE daily email newsletter.